Asia Pacific HIV Diagnostics Market Witnessing Boom with High Demand for Diagnostic Kits

 

Asia Pacific HIV Diagnostics Market
Asia Pacific HIV Diagnostics Market

Overview:

There are many different types of tests used to detect or diagnose HIV. Blood tests, which involve drawing a sample of your blood from a vein, are the most common test. They look for antigens or antibodies to HIV. These tests can start finding HIV as soon as 18 to 90 days after infection. There are also rapid HIV tests done at home that can detect HIV within 30 minutes. Laboratory tests can detect HIV antigens or antibodies in blood drawn from a vein or a sample of oral fluid or urine. The tests are usually ordered after an individual has been exposed to HIV or after a doctor suspects patient has the virus.

Market Dynamics:

Presence of high population pool in Asia Pacific is expected to augment growth of the Asia Pacific HIV diagnostics market over the forecast period. Over the time, population of this region has increased progressively along with the need for diagnostics for infectious diseases. The demand for new HIV diagnostics is also increasing in the region, further driving growth of the market. For instance, according to the World Bank Data, the number of population across East Asia & Pacific increased from 2.35 billion in 2019 to 2.37 billion in 2021.

However, factors such as social ostracism and stigma around HIV infections and diseases are projected to hamper growth of the Asia Pacific HIV diagnostics market over the forecast period.

Impact of COVID-19:

The outbreak of COVID-19 pandemic negatively impacted the Asia Pacific HIV diagnostics market. The virus outbreak emerged in Wuhan, China, and further impacted more than 100 countries across the globe. The number of people infected with COVID-19 was significantly high in Asia Pacific. Due to this, the demand for tests kits for COVID-19 cases increased rapidly, and the demand for HIV diagnostic declined, as the primary focus across several countries was COVID-19 patients. Thus, the market was adversely impacted by the pandemic.

Key Takeaways:

·         The Asia Pacific HIV diagnostics market is anticipated to grow with a CAGR of 12.4% during the forecast period, due to rise in initiatives by governments of countries in this region to bring up HIV diagnosis. For instance, in February 2022, the government of India announced that it is allowing 5% import duty on diagnostics kits to detect HIV and Hepatitis B in order to increase domestic manufacturing.

·         Launch of novel diagnostic techniques for HIV tests is a major trend in the Asia Pacific HIV diagnostics market. For instance, in August 2022, Molbio Diagnostics, a leading in-vitro diagnostics company introduced a novel test for differential diagnosis of HIV I and HIV II. The new technology offers with viral loads within 60 minutes.

·         Key Players active in the Asia Pacific HIV diagnostics market are Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Merck KGaA, Becton, and Dickinson and Company, F. Hoffmann-La Roche AG, Atomo Diagnostics, MedMira Inc., Siemens Healthineers, Inc., and bioLytical Laboratories Inc.

Comments

Post a Comment

Popular posts from this blog

Recycled Construction Aggregates Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Image
  Recycled Construction Aggregates Market Introduction: The Recycled Construction Aggregates Market has gained significant traction in recent years, driven by increasing environmental concerns, resource scarcity, and the growing emphasis on sustainable construction practices. Recycled construction aggregates, derived from the processing and recycling of construction and demolition waste materials, offer several benefits such as reduced demand for virgin materials, decreased landfill waste, and lower carbon footprint. The market for recycled construction aggregates is expected to witness substantial growth and present lucrative opportunities for market players. Market Size and Share: The global recycled construction aggregates market is projected to surpass  6.2 million tons  by the end of 2027 in terms of volume, exhibiting a CAGR of  6.0%  during the forecast period  (2020 to 2027) . The market is driven by stringent environmental regulations, governmen...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more